Product Information
PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1148 per EA under NDC 60219203801. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Apr 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219203801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216598FDA Approved
4/17/2023
TE Code
AB
On Market Since
4/21/2023
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 60.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1148 per EA |
|---|---|
| All-time high | $0.2933 (Sep 13, 2023) |
| All-time low | $0.1130 (Jul 22, 2026) |
| 52-week high | $0.1520 |
| 52-week low | $0.1130 |
| Median price | $0.1531 |
| Average price | $0.1716 |
| Largest weekly change | +71.7% (Aug 21, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the prochlorperazine maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
prochlorperazine maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1148 per EA (NDC 60219203801), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 60.9%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?
Since Sep 6, 2023, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1130 (Jul 22, 2026) to a high of $0.2933 (Sep 13, 2023), with a median of $0.1531 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PROCHLORPERAZINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCHLORPERAZINE 5 MG TABLET?
PROCHLORPERAZINE 5 MG TABLET (NDC 60219203801) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.